Dolobid and Oedema peripheral - a phase IV clinical study of FDA data

Summary:

Oedema peripheral is found among people who take Dolobid, especially for people who are female, 40-49 old.

The phase IV clinical study analyzes which people take Dolobid and have Oedema peripheral. It is created by eHealthMe based on reports of 340 people who have side effects when taking Dolobid from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 22, 2022

340 people reported to have side effects when taking Dolobid.
Among them, 15 people (4.41%) have Oedema peripheral.


What is Dolobid?

Dolobid has active ingredients of diflunisal. eHealthMe is studying from 347 Dolobid users for its effectiveness, alternative drugs and more.

What is Oedema peripheral?

Oedema peripheral (superficial swelling) is found to be associated with 3,376 drugs and 3,338 conditions by eHealthMe.

Number of Dolobid and Oedema peripheral reports submitted per year:

Could Dolobid cause Oedema peripheral?

Gender of people who have Oedema peripheral when taking Dolobid*:

Click here to view

Age of people who have Oedema peripheral when taking Dolobid *:

Click here to view

Common drugs people take besides Dolobid *:

Click here to view

Common side effects people have besides Oedema peripheral *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Dolobid and have Oedema peripheral?

Check whether Oedema peripheral is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Oedema peripheral and when was it recovered:

Expand to all the drugs that have ingredients of diflunisal:

Alternative drugs to, pros and cons of Dolobid:

Oedema peripheral treatments and more:

COVID vaccines that are related to Oedema peripheral:

Common drugs associated with Oedema peripheral:

All the drugs that are associated with Oedema peripheral:

Common conditions associated with Oedema peripheral:

All the conditions that are associated with Oedema peripheral:

How the study uses the data?

The study uses data from the FDA. It is based on diflunisal (the active ingredients of Dolobid) and Dolobid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: